Evidence map›Paper›PMID 32201859›Full record

ArticleCrohn's & colitis 3602020

TELEmedicine for Patients With Inflammatory Bowel Disease (TELE-IBD) Does Not Improve Depressive Symptoms or General Quality of Life Compared With Standard Care at Tertiary Referral Centers.

Matthew Schliep, Kenechukwu Chudy-Onwugaje, Ameer Abutaleb, Patricia Langenberg, Miguel Regueiro, David A Schwartz, J Kathleen Tracy, Leyla Ghazi, Seema A Patil, Sandra Quezada and 6 more

Open access · goldAbstract read
In one paragraph

Article in Crohn's & colitis 360, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 6 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 6 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Remote care through telehealth for people with inflammatory bowel disease.The Cochrane database of systematic reviews · 2023
    Pooled it
  6. Pooled it
  7. Models of outpatient care delivery in inflammatory bowel disease: a scoping review.Journal of the Canadian Association of Gastroenterology · 2025
    Article
  8. Review
  9. Review
  10. The 2023 Impact of Inflammatory Bowel Disease in Canada: Access to and Models of Care.Journal of the Canadian Association of Gastroenterology · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 1 country.

Matthew SchliepSchool of Medicine, University of Maryland, Baltimore, Maryland, USA.
Kenechukwu Chudy-OnwugajeDivision of Gastroenterology and Hepatology, Department of Medicine, University of Maryland, Baltimore, Maryland, USA.
Ameer AbutalebDivision of Gastroenterology and Hepatology, Department of Medicine, University of Maryland, Baltimore, Maryland, USA.
Patricia LangenbergDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA.
Miguel RegueiroDepartment of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Ohio, USA.
David A SchwartzDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
J Kathleen TracyDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA.
Leyla GhaziDepartment of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Seema A PatilDivision of Gastroenterology and Hepatology, Department of Medicine, University of Maryland, Baltimore, Maryland, USA.
Sandra QuezadaDivision of Gastroenterology and Hepatology, Department of Medicine, University of Maryland, Baltimore, Maryland, USA.
Katharine RussmanDivision of Gastroenterology and Hepatology, Department of Medicine, University of Maryland, Baltimore, Maryland, USA.
Sara HorstDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Dawn BeaulieuDivision of Gastroenterology, Hepatology and Nutrition, Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.
Charlene QuinnDepartment of Epidemiology and Public Health, University of Maryland, Baltimore, Maryland, USA.
Guruprasad JambaulikarDepartment of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Raymond K CrossDivision of Gastroenterology and Hepatology, Department of Medicine, University of Maryland, Baltimore, Maryland, USA.
University of Maryland, Baltimore · USVanderbilt University · USBrigham and Women's Hospital · USCleveland Clinic · USDartmouth–Hitchcock Medical Center · US

Funding

Research Training in Gastroenterology and HepatologyT32DK067872 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RAUFMAN, JEAN-PIERRE · 2005 to 2024
$7.2M
AHRQ HHS R01 HS018975NIDDK NIH HHS T32 DK067872
6 · The paper itself

Abstract

backgroundDepression is common in patients with inflammatory bowel disease (IBD) and contributes to poor quality of life (QoL). The use of information technology for the remote management of patients with IBD is growing, but little is known about its impact on depressive symptoms (DS) and QoL. We aimed to evaluate the impact of telemedicine on DS and generic QoL in IBD patients.

methodsWe analyzed data from the Telemedicine for Patients with IBD (TELE-IBD) study. During this 12-month clinical trial, patients were randomized to receive text message-based telemedicine weekly (TELE-IBD W), every other week (TELE-IBD EOW), or to standard care. Depressive symptoms and QoL were assessed over time with the Mental Health Inventory 5 (MHI-5) and the Short Form 12 (SF-12), respectively. We compared the change in MHI-5 and SF-12 (with separate physical (PCS) and mental component summary (MCS) scores) between the study arms.

resultsA total of 217 participants were included in this analysis. After 1 year, there was no significant difference in the change in MHI-5 (TELE-IBD W +3.0 vs TELE-IBD EOW +0.7 vs standard care +3.4;

conclusionsText message-based telemedicine does not improve DS or QoL when compared with standard care in IBD patients treated at tertiary referral centers. Further studies are needed to determine whether telemedicine improves DS or QoL in settings with few resources.

Indexed as

depressioninflammatory bowel diseasequality of lifetelemedicinetext message

Identifiers

PMID32201859
PMCPMC7067223
OpenAlexW3004140154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.